MedPath

Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women

Phase 1
Terminated
Conditions
Pain
Interventions
Registration Number
NCT01866917
Lead Sponsor
Montefiore Medical Center
Brief Summary

Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
35
Inclusion Criteria
  • BMI greater than or equal to 30, women undergoing laparoscopic or robotic in-patient procedures
Exclusion Criteria
  • Conversions, non-obese women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SalinePlaceboPatients will receive Normal saline 20cc injectate from a study labeled syringe
TAPRopivacaine 0.5% 20cc injectate bilaterallyPatients will receive Ropivicaine 0.5% 20cc injectate from a study labeled syringe
Primary Outcome Measures
NameTimeMethod
Postoperative Numeric Pain Rating Score (NPRS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)0, 1, and 2 hours

Pain assessments by verbal numerical pain score (NPS) at 0, 1 and 2 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable

Postoperative Numeric Pain Score (NPS) 0-10 Scale; (0 is Equivalent to no Pain; 10 is Equivalent to the Worst Pain Imaginable)4hrs, 8hrs, 12hrs, and 24hrs.

Pain assessments by verbal numerical pain score (NPS) at 4, 8, 12 and 24 hours prior to discharge in the Post Anesthesia Care Unit. The 10 point NPS scale ranges from 0-10 with 0 being equivalent to no pain and a value of 10 being equivalent to the worst pain imaginable

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Moses Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath